Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Radial Approach, 1st choice in Acute Coronary Syndromes

Original title: Radial Versus Femoral Randomized Investigation in ST-Segment Elevation Acute Coronary síndrome. The RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) Study. Reference: Enrico Romagnoli et al. J Am Coll Cardiol 2012;60:2481–9.

Bleeding in patients with acute coronary syndromes (ACS) is an independent predictor of morbidity and mortality. Until today, evidence supporting the radial approach came from studies not strong enough to show significant difference in hard clinical end points.

This multicenter study included 1001 patients with ST segment elevation ACS randomized 1:1, radial vs. femoral. All patients were positive for Allen’s tested in both hands and operators were required that at least a 50% of performed angioplasty procedures by radial approach.

Primary end point was a composite between cardiac death, infarction, stroke, revascularization and non surgical bleeding, Baseline characteristics were well balanced, around 10% were in Killip class III/IV, and 8%required intra-aortic balloon counterpulsation. There were no differences in symptom/balloon time and door/balloon time between the groups. The overall rate of vascular approach crossover was 6.1%.

The primary end point was significantly lower in the radial group compared to the femoral (13.6% vs. 21% p=0.003). Cardiac death was also significantly lower in the radial group (5.2% vs. 9.2% p=0.02) and there were no differences in infarction (1.2% vs. 1.4% p=1), revascularization (1.2% vs. 1.8% p=0.6) or stroke occurrence (0.8% vs. 0.6% p=0.72).

Bleeding occurred in 10% of procedures and was lower in the radial group (7.8% vs. 12.2% p=0.026); this difference was due to a reduction of 60% in bleeding associated to access site. Non surgical bleeding was 53% of all bleeding and was similar in both groups (5.2% vs. 5.4% p=1).

Using TIMI criteria, no differences were observed in major bleeding but differences were noted in minor bleeding (radial 4% vs. femoral 7.2% p=0.038). Hospitalization was also significantly lower for those accessed by radial approach.

Conclusion 

The RIFLE-STEACS trial clearly shows the advantages of the radial approach vs. the femoral approach in patients with ST segment elevation ACS.

Editorial Comment:

This is the first study with enough statistical strength to show different in hard clinical end points to make the radial approach the number one choice, also in the emergency room. The low frequency use of Bivalirudin (a mere 8%, a more frequent use may reduce the gap in terms of bleeding), and operator training were study limitations.

Though the radial approach significantly reduces bleeding and mortality, bleeding events not associated with access sites are still 53%. We should use the radial approach but also assess patients with bleeding risk scores (e.g. CRUSADE) to adjust antiplatelet and antithrombotics on a case by case basis. 

SOLACI.ORG

More articles by this author

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...

Calcified Nodules and Their Treatment with Rotational Atherectomy

Calcified nodules (CN) represent one of the most complex phenotypes to treat in coronary intervention. They are mainly associated with the need for repeat...

Complex PCI: higher ischemic and bleeding risk in contemporary practice

Advances in pharmacological therapies, equipment, and devices have enabled percutaneous coronary interventions (PCI) to be performed in a growing number of patients with a...

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...